Return to program book search
Recent Advances in Treatment of Pigmentary Disorders
Monday, March 24
10:00 AM - 12:00 PM
Rebat M. Halder, MD, FAAD
- Andrew F. Alexis, MD, FAAD
- Iltefat H. Hamzavi, MD, FAAD
Following this course, the attendee should be able to:
- Assess the effectiveness of recently developed treatments for pigmentary disorders.
- Choose effective new treatments for patients with pigmentary disorders.
Dyspigmentation in the form of either hyperpigmentation, hypopigmentation or depigmentation is often psychologically devastating. Despite being common, pigmentary disorders remain difficult to treat. There have been a number of recent advances that are much more effective in treating vitiligo such as grafting, melanocyte transplantation and new modulators of phototherapy. Disorders of hyperpigmentation, such as postinflammatory hyperpigmentation and melasma are being treated with new topical agents such as licorice, rucinol, mulberry and ellagic acid. These disorders of hyperpigmentation can now be treated with lasers such as Q-switched Nd:YAG and fractional photothermolysis, and also with intense pulsed light.
|Monday, March 24|
|10:00 AM||Why Are Pigmentary Disorders Difficult to Treat? / Dr. Halder|
|10:10 AM||New Topical Agents for Treating Disorders of Hyperpigmentation / Dr. Halder|
|10:30 AM||Lasers and Other Light Sources for Treating Disorders of Hyperpigmentation / Dr. Alexis|
|10:50 AM||New Modulators of Phototherapy for Vitiligo / Dr. Hamzavi|
|11:05 AM||Mixed Melanocyte/Keratinocyte Culture Transplants for Vitiligo / Dr. Hamzavi|
|11:25 AM||Suction Blister Grafting for Vitiligo / Dr. Halder|
|11:45 AM||Questions and Answers / All faculty|